ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 676369 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 676369; 2) Community: the network communities that were significantly associated with the response to NSC 676369; 3) Molecule: the relationships between components within communities and NSC 676369; 4) MDR: the compounds that were significantly associated with the NSC 676369.

NSC Compound Enrichment Correlation
NSC 687958 Null 0.0062362367141553 0.29896392
NSC 304421 LEUROSINE-N-OXIDE 0.0065871594677386 -0.10130324
NSC 684909 2,6-Pyrimidinediamine, 4-chloro-5-[(4-chlorophenyl)azo]- N(6)-[[1-(hydroxymethyl)-3-(phenylmethoxy)cyclobutyl] methyl]-, (Isomer A)-, stereoisomer of NSC-684910 0.0065871594677386 0.35723392
NSC 717101 Null 0.0065871594677386 0.14400664
NSC 698280 Null 0.0070787592519192 0.3670701
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.0070787592519192 -0.10839527
NSC 306107 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, bis[tris(4-aminophenyl)methyl] ester 0.00707875925191925 -0.25134038
NSC 637459 Macrocalyxoformin B (Rabdosia diterpenoids) 0.00707875925191925 0.33687834
NSC 675251 Null 0.00707875925191925 0.11953358
NSC 737733 1N-[4-chloro-2-(2-chlorobenzoyl)phenyl]-2-[4-(2-pheridyl)hex ahydro-1-pyrazinyl]acetamide 0.00888636978630782 0.26719852
Total:45  Current:6    [First] [Prev] [Next] [Last]